<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Evaluation of adults with ascites</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Evaluation of adults with ascites</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Evaluation of adults with ascites</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bruce A Runyon, MD, FAASLD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keith D Lindor, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen M Robson, MD, MBA, FACG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 21, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Accumulation of fluid within the peritoneal cavity results in ascites. In the United States, ascites is most often due to portal hypertension resulting from cirrhosis. Other common causes include malignancy and heart failure. Successful treatment of ascites depends upon an accurate diagnosis of its cause  (<a class="graphic graphic_table graphicRef56069" href="/z/d/graphic/56069.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef51299" href="/z/d/graphic/51299.html" rel="external">table 2</a> and <a class="graphic graphic_table graphicRef62032" href="/z/d/graphic/62032.html" rel="external">table 3</a> and <a class="graphic graphic_algorithm graphicRef77605" href="/z/d/graphic/77605.html" rel="external">algorithm 1</a>) [<a href="#rid1">1</a>]. </p><p>This topic will review the evaluation of adults with ascites. Performance of paracentesis, specific causes of ascites, the initial therapy of ascites in patients with cirrhosis, and the treatment of refractory ascites are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/16203.html" rel="external">"Diagnostic and therapeutic abdominal paracentesis"</a> and  <a class="medical medical_review" href="/z/d/html/1240.html" rel="external">"Malignancy-related ascites"</a> and  <a class="medical medical_review" href="/z/d/html/1235.html" rel="external">"Chylous, bloody, and pancreatic ascites"</a> and  <a class="medical medical_review" href="/z/d/html/1238.html" rel="external">"Abdominal tuberculosis"</a> and  <a class="medical medical_review" href="/z/d/html/1256.html" rel="external">"Ascites in adults with cirrhosis: Initial therapy"</a> and  <a class="medical medical_review" href="/z/d/html/1258.html" rel="external">"Ascites in adults with cirrhosis: Diuretic-resistant ascites"</a>.)</p><p>The American Association for the Study of Liver Diseases (AASLD) has updated its practice guidance on the management of adult patients with ascites due to cirrhosis [<a href="#rid2">2</a>]. The discussion that follows is generally consistent with that guidance.</p><p class="headingAnchor" id="H25272217"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>There are numerous causes of ascites, but the most common cause of ascites in the United States is cirrhosis, which accounts for approximately 80 percent of cases  (<a class="graphic graphic_table graphicRef56069" href="/z/d/graphic/56069.html" rel="external">table 1</a>) [<a href="#rid3">3</a>]. Up to 19 percent of patients with cirrhosis will have hemorrhagic ascites, which may develop spontaneously (72 percent probably due to bloody lymph and 13 percent due to hepatocellular carcinoma) or following paracentesis [<a href="#rid4">4</a>]. Other common causes of ascites include malignancy-related ascites and ascites due to heart failure. </p><p>Ascites can be classified based on the underlying pathophysiology [<a href="#rid5">5</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Portal hypertension</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cirrhosis (see  <a class="medical medical_review" href="/z/d/html/1259.html" rel="external">"Pathogenesis of ascites in patients with cirrhosis"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Alcoholic hepatitis (see  <a class="medical medical_review" href="/z/d/html/86934.html" rel="external">"Alcoholic hepatitis: Clinical manifestations and diagnosis"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Acute liver failure (see  <a class="medical medical_review" href="/z/d/html/3574.html" rel="external">"Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis", section on 'Clinical manifestations'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hepatic veno-occlusive disease (eg, Budd-Chiari syndrome) (see  <a class="medical medical_review" href="/z/d/html/3562.html" rel="external">"Budd-Chiari syndrome: Epidemiology, clinical manifestations, and diagnosis", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/129806.html" rel="external">"Hepatic sinusoidal obstruction syndrome (veno-occlusive disease) in adults", section on 'Clinical presentation'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Heart failure (see  <a class="medical medical_review" href="/z/d/html/3506.html" rel="external">"Pathophysiology of heart failure with reduced ejection fraction: Hemodynamic alterations and remodeling", section on 'Pressure-volume relationships in HF'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Constrictive pericarditis (see  <a class="medical medical_review" href="/z/d/html/140205.html" rel="external">"Constrictive pericarditis: Clinical features and causes", section on 'Pathophysiology'</a> and  <a class="medical medical_review" href="/z/d/html/140205.html" rel="external">"Constrictive pericarditis: Clinical features and causes", section on 'Incidence and causes'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hemodialysis-associated ascites (nephrogenic ascites) (see  <a class="medical medical_review" href="/z/d/html/1897.html" rel="external">"Unique aspects of gastrointestinal disease in patients on dialysis", section on 'Hemodialysis-associated ascites'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypoalbuminemia</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Nephrotic syndrome (see  <a class="medical medical_review" href="/z/d/html/3084.html" rel="external">"Overview of heavy proteinuria and the nephrotic syndrome", section on 'Pathophysiology'</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Protein-losing enteropathy </p><p class="bulletIndent2"><span class="glyph">•</span>Severe malnutrition</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Peritoneal disease</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Malignant ascites (eg, ovarian cancer, mesothelioma) (see  <a class="medical medical_review" href="/z/d/html/1240.html" rel="external">"Malignancy-related ascites", section on 'Etiology and pathogenesis'</a>).</p><p class="bulletIndent2"><span class="glyph">•</span>Infectious peritonitis (eg, tuberculosis or fungal infection) (see  <a class="medical medical_review" href="/z/d/html/1238.html" rel="external">"Abdominal tuberculosis"</a> and  <a class="medical medical_review" href="/z/d/html/1982.html" rel="external">"Fungal peritonitis in peritoneal dialysis"</a>).</p><p class="bulletIndent2"><span class="glyph">•</span>Eosinophilic gastroenteritis (see  <a class="medical medical_review" href="/z/d/html/2536.html" rel="external">"Eosinophilic gastrointestinal diseases", section on 'Serosal disease'</a>).</p><p class="bulletIndent2"><span class="glyph">•</span>Starch granulomatous peritonitis.</p><p class="bulletIndent2"><span class="glyph">•</span>Peritoneal dialysis (see  <a class="medical medical_review" href="/z/d/html/1869.html" rel="external">"Clinical manifestations and diagnosis of peritonitis in peritoneal dialysis"</a>).</p><p class="bulletIndent2"><span class="glyph">•</span>Multicystic mesothelioma (peritoneal inclusion cysts) [<a href="#rid6">6</a>] (see  <a class="medical medical_review" href="/z/d/html/2504.html" rel="external">"Malignant peritoneal mesothelioma: Epidemiology, risk factors, clinical presentation, diagnosis, and staging", section on 'Multicystic mesothelioma'</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other etiologies</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Chylous ascites (see  <a class="medical medical_review" href="/z/d/html/1235.html" rel="external">"Chylous, bloody, and pancreatic ascites", section on 'Chylous ascites'</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Pancreatic ascites (eg, from a disrupted pancreatic duct) (see  <a class="medical medical_review" href="/z/d/html/1235.html" rel="external">"Chylous, bloody, and pancreatic ascites", section on 'Pancreatic ascites'</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Myxedema (see  <a class="medical medical_review" href="/z/d/html/7846.html" rel="external">"Clinical manifestations of hypothyroidism", section on 'Gastrointestinal disorders'</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Hemoperitoneum (see  <a class="medical medical_review" href="/z/d/html/1235.html" rel="external">"Chylous, bloody, and pancreatic ascites", section on 'Bloody ascites'</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Urologic injury (See  <a class="medical medical_review" href="/z/d/html/3276.html" rel="external">"Urinary tract injury in gynecologic surgery: Identification and management"</a>.)</p><p></p><p>There is also long list of rare causes of ascites that includes disorders such as abdominal pregnancy, Whipple disease, and sarcoidosis  (<a class="graphic graphic_table graphicRef51299" href="/z/d/graphic/51299.html" rel="external">table 2</a>) [<a href="#rid7">7-39</a>].</p><p>Approximately 5 percent of patients with ascites have more than one cause, such as cirrhosis plus one of the following: tuberculosis peritonitis, peritoneal carcinomatosis, heart failure, or diabetic nephropathy [<a href="#rid40">40</a>]. Obesity-related complications (including diabetic nephropathy, heart failure, and cirrhosis due to nonalcoholic steatohepatitis) commonly coexist as causes of ascites. Patients with more than one cause for ascites formation are often the most difficult to diagnose because each partial cause may not be severe enough in-and-of itself to lead to fluid retention; it is the combination of partial causes that leads to ascites formation.</p><p class="headingAnchor" id="H25272225"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Patients with ascites typically have abdominal distension that may be associated with symptoms such as abdominal discomfort, shortness of breath, and weight gain. In addition, signs and symptoms related to the underlying cause of the ascites, such as cirrhosis or malignancy, may also be seen.</p><p class="headingAnchor" id="H341237666"><span class="h2">Symptoms</span><span class="headingEndMark"> — </span>Patients with ascites typically report progressive abdominal distension that may be painless or associated with abdominal discomfort. The time course over which the distension develops depends on the etiology of the ascites. It may develop over the course of days (eg, bloody ascites due to trauma) or months (eg, malignant ascites). Ascites due to cirrhosis and/or alcoholic hepatitis usually develops rapidly over a few weeks. Patients may also complain of weight gain, shortness of breath, early satiety, and dyspnea resulting from fluid accumulation and increased abdominal pressure. Patients with spontaneous bacterial peritonitis may also have symptoms such as fever, abdominal tenderness, and altered mental status. (See  <a class="medical medical_review" href="/z/d/html/1247.html" rel="external">"Spontaneous bacterial peritonitis in adults: Clinical manifestations", section on 'Clinical manifestations'</a>.)</p><p>Patients with cirrhosis may have other symptoms associated with hepatic decompensation, such as confusion or evidence of gastrointestinal bleeding. Patients with malignant ascites may have symptoms related to the underlying malignancy, such as weight loss, whereas patients with ascites due to heart failure may report dyspnea, orthopnea, and peripheral edema. Patients with chylous ascites may report diarrhea and steatorrhea, malnutrition, edema, nausea, enlarged lymph nodes, early satiety, fevers, and night sweats [<a href="#rid41">41-44</a>]. (See  <a class="medical medical_review" href="/z/d/html/1263.html" rel="external">"Cirrhosis in adults: Overview of complications, general management, and prognosis", section on 'Major complications'</a> and  <a class="medical medical_review" href="/z/d/html/1240.html" rel="external">"Malignancy-related ascites", section on 'Etiology and pathogenesis'</a> and  <a class="medical medical_review" href="/z/d/html/1235.html" rel="external">"Chylous, bloody, and pancreatic ascites", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/3510.html" rel="external">"Heart failure: Clinical manifestations and diagnosis in adults", section on 'Clinical presentation'</a>.)</p><p class="headingAnchor" id="H341237441"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>Patients with ascites, regardless of the etiology, will typically have flank dullness on examination [<a href="#rid45">45</a>]. Patients may also have shifting dullness (a change in the location of dullness to percussion when the patient is turned due to movement of the ascites). We do not check for an abdominal fluid wave because the maneuver requires two examiners and is often not accurate. If pleural effusions are present, the right effusion is usually greater than the left. Pleural effusions are manifested by decreased breath sounds or dullness to percussion.</p><p>Almost all patients with cirrhosis severe enough to lead to ascites formation have stigmata of cirrhosis on physical examination. Stigmata that suggest the presence of cirrhosis include spider angioma, palmar erythema, and abdominal wall collaterals. Spider angiomata are most apparent on the face, neck, shoulders, and upper chest, and are unusual below the umbilicus. The palmar erythema of cirrhosis is "blotchy" and most prominent on the hypothenar eminence and next most prominent on the thenar eminence, with sparing of the center of the palm. However, spider angiomata and palmar erythema may be difficult to detect in patients with dark skin. Abdominal wall collaterals are most apparent starting at the umbilicus and extending cephalad. The appearance is thought by some to resemble the head of the mythical Gorgon Medusa; however, the recanalized umbilical vein enlarges the veins cephalad, not caudad, from the umbilicus. (See  <a class="medical medical_review" href="/z/d/html/1253.html" rel="external">"Cirrhosis in adults: Etiologies, clinical manifestations, and diagnosis", section on 'Clinical manifestations'</a>.)</p><p>Many patients with advanced liver disease also have jaundice, muscle wasting, gynecomastia, and leukonychia (white nails). The lunula of the nail may be enlarged with a terminal red line. The liver and spleen may be palpable. Parotid enlargement may be present but is probably due to alcohol and not cirrhosis per se. </p><p>An umbilical nodule that is not bowel or omentum (ie, a Sister Mary Joseph nodule) provides evidence for cancer as the cause of ascites. Gastric cancer, colon cancer, hepatocellular carcinoma, or lymphoma can cause ascites accompanied by an umbilical nodule.</p><p>If the ascites is the result of heart failure, physical examination findings may include jugular venous distension, pulmonary congestion, or peripheral edema. An elevated jugular venous pressure suggests that heart failure or constrictive pericarditis may be the cause (or at least one cause) of ascites. On the other hand, cirrhosis in the absence of tense ascites, pulmonary hypertension, or renal insufficiency is associated with no jugular venous distension. (See  <a class="medical medical_review" href="/z/d/html/3510.html" rel="external">"Heart failure: Clinical manifestations and diagnosis in adults", section on 'Physical examination'</a>.)</p><p>Findings that may be present on physical examination in patients with chylous ascites include lower extremity edema, lymphadenopathy, cachexia, abdominal masses, and temporal wasting [<a href="#rid46">46</a>]. </p><p class="headingAnchor" id="H341237824"><span class="h2">Laboratory tests</span><span class="headingEndMark"> — </span>Laboratory test abnormalities seen in patients with ascites are related to the underlying cause of the ascites. Patients with cirrhosis or heart failure may have abnormal liver tests and evidence of renal failure. Patients with cirrhosis may also have an elevated international normalized ratio, hypoalbuminemia, thrombocytopenia, anemia, and leukopenia. Patients who have developed spontaneous bacterial peritonitis may have a leukocytosis, metabolic acidosis, and azotemia. (See  <a class="medical medical_review" href="/z/d/html/1253.html" rel="external">"Cirrhosis in adults: Etiologies, clinical manifestations, and diagnosis", section on 'Laboratory findings'</a> and  <a class="medical medical_review" href="/z/d/html/3485.html" rel="external">"Determining the etiology and severity of heart failure or cardiomyopathy", section on 'Initial blood tests'</a> and  <a class="medical medical_review" href="/z/d/html/1247.html" rel="external">"Spontaneous bacterial peritonitis in adults: Clinical manifestations", section on 'Laboratory abnormalities'</a>.)</p><p>Patient with chylous ascites may have hypoalbuminemia, decreased gamma globulin levels, and lymphopenia. (See  <a class="medical medical_review" href="/z/d/html/1235.html" rel="external">"Chylous, bloody, and pancreatic ascites", section on 'Clinical manifestations'</a>.)</p><p class="headingAnchor" id="H11"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of ascites is established with a combination of physical examination and abdominal imaging (usually ultrasonography). Once the diagnosis of ascites is made, the next step is to look for the cause. This typically includes a paracentesis to evaluate the ascitic fluid. (See <a class="local">'Determining the cause of the ascites'</a> below.)</p><p>A grading system for ascites has been proposed by the International Ascites Club [<a href="#rid47">47</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Grade 1 – Mild ascites detectable only by ultrasound examination</p><p class="bulletIndent1"><span class="glyph">●</span>Grade 2 – Moderate ascites manifested by moderate symmetrical distension of the abdomen</p><p class="bulletIndent1"><span class="glyph">●</span>Grade 3 – Large or gross ascites with marked abdominal distension</p><p></p><p>However, the validity of the grading system has not yet been established. In particular, data on the natural history of "grade 1" ascites are limited [<a href="#rid48">48-50</a>]. In an observational study including 547 patients with cirrhosis with median follow up of 29 months, there was no significant difference in rates of developing overt ascites for patients with grade 1 ascites compared with no ascites [<a href="#rid50">50</a>]. </p><p>An older system that grades ascites from 1+ to 4+ is also used. In this system 1+ is minimal and barely detectable, 2+ is moderate, 3+ is massive but not tense, and 4+ is massive and tense [<a href="#rid51">51</a>].</p><p class="headingAnchor" id="H341237938"><span class="h2">History and physical examination</span><span class="headingEndMark"> — </span>Ascites is frequently suspected based upon the history and physical examination. The most helpful physical finding in confirming the presence of ascites is flank dullness [<a href="#rid45">45</a>]. When flank dullness is detected, it is useful to see if it shifts with rotation of the patient (ie, shifting dullness). </p><p>However, the accuracy of physical findings is variable depending in part upon the amount of fluid present, the technique used to examine the patient, and the clinical setting (eg, detection may be more difficult in patients who are obese). In a study comparing various physical findings with ultrasound as the gold standard, the sensitivity and specificity of the physical examination for detecting ascites ranged from 50 to 94 percent and 29 to 82 percent, respectively [<a href="#rid45">45</a>].</p><p class="headingAnchor" id="H13"><span class="h2">Imaging tests</span><span class="headingEndMark"> — </span>Patients suspected of having ascites based on history and physical examination should undergo imaging to confirm the presence of ascites and to look for evidence of cirrhosis or malignancy. Ultrasound is probably the most cost-effective modality [<a href="#rid52">52</a>]. Pocket-sized inexpensive machines are available that sync with smart phones. These may dramatically increase use of this modality. </p><p>Another advantage of ultrasound is that it involves no radiation or intravenous access, and no risk of contrast allergy or nephropathy. If a computed tomographic (CT) scan is performed, ascites is easily seen  (<a class="graphic graphic_diagnosticimage graphicRef77598" href="/z/d/graphic/77598.html" rel="external">image 1</a>).</p><p>The usual liver ultrasound focuses attention on the gallbladder and does not examine the spleen. Specifically ordering a "complete abdominal ultrasound" is more likely to provide the needed information. The details of the ordering should be coordinated with the local imaging team. </p><p>In patients with cirrhosis, ultrasound, CT, or magnetic resonance imaging (MRI) may reveal evidence of a nodular liver. Ultrasound findings in patients with portal hypertension may include dilation of the portal vein to ≥13 mm, dilation of the splenic and superior mesenteric veins to ≥11 mm, reduction in portal venous blood flow velocity, splenomegaly (greatest dimension &gt;12 cm), and recanalization of the umbilical vein [<a href="#rid53">53,54</a>]. (See  <a class="medical medical_review" href="/z/d/html/1253.html" rel="external">"Cirrhosis in adults: Etiologies, clinical manifestations, and diagnosis", section on 'Radiologic findings'</a>.)</p><p>Ultrasound may also reveal evidence of hepatocellular carcinoma, which can be further evaluated with CT or MRI. (See  <a class="medical medical_review" href="/z/d/html/3575.html" rel="external">"Approach to the adult patient with an incidental solid liver lesion"</a>.)</p><p class="headingAnchor" id="H56451758"><span class="h2">Paracentesis</span><span class="headingEndMark"> — </span>Abdominal paracentesis is central to determining the cause of ascites and in ruling out or confirming spontaneous bacterial peritonitis (SBP). In patients with SBP, mortality increases by 3.3 percent/hour of delay in performing a paracentesis [<a href="#rid55">55</a>]. (See <a class="local">'Determining the cause of the ascites'</a> below.)</p><p>The performance of paracentesis is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/16203.html" rel="external">"Diagnostic and therapeutic abdominal paracentesis"</a>.)</p><p class="headingAnchor" id="H64022603"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of ascites includes abdominal obesity, giant ovarian or mesenteric cyst, and bowel obstruction (mechanical or functional). Obesity decreases the accuracy of the abdominal examination [<a href="#rid56">56</a>]. These entities can typically be differentiated from ascites based on physical examination findings and abdominal imaging. (See  <a class="medical medical_review" href="/z/d/html/8037.html" rel="external">"Etiologies, clinical manifestations, and diagnosis of mechanical small bowel obstruction in adults"</a> and  <a class="medical medical_review" href="/z/d/html/8042.html" rel="external">"Postoperative ileus"</a> and  <a class="medical medical_review" href="/z/d/html/2531.html" rel="external">"Acute colonic pseudo-obstruction (Ogilvie's syndrome)"</a> and  <a class="medical medical_review" href="/z/d/html/2555.html" rel="external">"Sigmoid volvulus"</a>.)</p><p>The description of the onset of symptoms may be helpful for distinguishing obesity from ascites. Patients frequently seek medical attention within a few weeks of ascites development. The fluid usually accumulates rapidly, and patients are intolerant of the distension and the associated early satiety and shortness of breath. By contrast, the thickening abdominal wall and enlarging omentum associated with obesity develop over months or years.</p><p class="headingAnchor" id="H56451750"><span class="h1">DETERMINING THE CAUSE OF THE ASCITES</span><span class="headingEndMark"> — </span>Abdominal paracentesis is crucial for determining the cause of a patient's ascites, though physical examination findings and abdominal imaging may suggest a cause for a patient's ascites, such as cirrhosis, malignancy, or heart failure. Abdominal paracentesis is indicated for all patients with new onset ascites  (<a class="graphic graphic_table graphicRef64189" data-inline-graphics="64189" href="/z/d/graphic/64189.html" rel="external">table 4</a>) [<a href="#rid57">57</a>]. (See <a class="local">'Physical examination'</a> above and <a class="local">'Imaging tests'</a> above and  <a class="medical medical_review" href="/z/d/html/16203.html" rel="external">"Diagnostic and therapeutic abdominal paracentesis"</a>.)</p><p class="headingAnchor" id="H64427665"><span class="h2">General approach</span><span class="headingEndMark"> — </span>The tests that are ordered on samples of ascitic fluid are determined by the clinical setting  (<a class="graphic graphic_table graphicRef62032" href="/z/d/graphic/62032.html" rel="external">table 3</a> and <a class="graphic graphic_algorithm graphicRef77605" href="/z/d/graphic/77605.html" rel="external">algorithm 1</a>). Two of the main issues that arise regarding ascites are:</p><p class="bulletIndent1"><span class="glyph">●</span>Is the fluid infected?</p><p class="bulletIndent1"><span class="glyph">●</span>Is portal hypertension present?</p><p></p><p>The routine tests to answer these questions are ordered on the first ascitic fluid sample. Additional tests may be indicated based on the clinical setting and results of initial testing. (See <a class="local">'Other ascitic fluid tests'</a> below and <a class="local">'Additional testing based on ascitic fluid analysis'</a> below.)</p><p>Initial tests that should be performed on the ascitic fluid include (see <a class="local">'Initial ascitic fluid tests'</a> below):</p><p class="bulletIndent1"><span class="glyph">●</span>Appearance assessment (eg, clear, bloody, cloudy, milky). </p><p class="bulletIndent1"><span class="glyph">●</span>Serum-to-ascites albumin gradient determination (SAAG)  (<a class="graphic graphic_table graphicRef81696" href="/z/d/graphic/81696.html" rel="external">table 5</a>).</p><p class="bulletIndent1"><span class="glyph">●</span>Cell count and differential.</p><p class="bulletIndent1"><span class="glyph">●</span>Total protein concentration.</p><p></p><p>Additional tests that may be performed to aid in confirming a diagnosis include (see <a class="local">'Other ascitic fluid tests'</a> below):</p><p class="bulletIndent1"><span class="glyph">●</span>Culture with bedside inoculation of aerobic and anaerobic blood culture bottles (infection, bowel perforation)</p><p class="bulletIndent1"><span class="glyph">●</span>Glucose concentration (malignancy, infection, bowel perforation)</p><p class="bulletIndent1"><span class="glyph">●</span>Lactate dehydrogenase concentration (malignancy, infection, bowel perforation)</p><p class="bulletIndent1"><span class="glyph">●</span>Gram stain (suspected bowel perforation)</p><p class="bulletIndent1"><span class="glyph">●</span>Amylase concentration (pancreatic ascites or bowel perforation)</p><p class="bulletIndent1"><span class="glyph">●</span>Tuberculosis smear, culture, and adenosine deaminase activity (tuberculous peritonitis)</p><p class="bulletIndent1"><span class="glyph">●</span>Cytology and possibly carcinoembryonic antigen level (malignancy)</p><p class="bulletIndent1"><span class="glyph">●</span>Triglyceride concentration (chylous ascites)</p><p class="bulletIndent1"><span class="glyph">●</span>Bilirubin concentration (bowel or biliary perforation)</p><p class="bulletIndent1"><span class="glyph">●</span>Serum pro-brain natriuretic peptide (heart failure)</p><p></p><p>These additional tests may be performed with the initial paracentesis if there is clinical suspicion for a particular disorder, or they may be performed on a subsequent paracentesis based on the results of initial testing.</p><p class="headingAnchor" id="H64023967"><span class="h2">Initial ascitic fluid tests</span><span class="headingEndMark"> — </span>The routine tests ordered on ascitic fluid samples include an analysis of the appearance, serum-to-ascites albumin gradient, cell count and differential, culture, and total protein  (<a class="graphic graphic_table graphicRef62032" href="/z/d/graphic/62032.html" rel="external">table 3</a> and <a class="graphic graphic_algorithm graphicRef77605" href="/z/d/graphic/77605.html" rel="external">algorithm 1</a>).</p><p class="headingAnchor" id="H341238844"><span class="h3">Appearance</span><span class="headingEndMark"> — </span>The gross appearance of the ascitic fluid can be helpful in the differential diagnosis. Clear fluid is typically seen in the setting of cirrhosis, turbid or cloudy fluid in the setting of infection, milky fluid in the setting of chylous ascites, and bloody fluid in the setting of malignancy or a traumatic paracentesis.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clear</strong> – Uncomplicated ascites in the setting of cirrhosis is usually translucent yellow; it can be completely clear if the bilirubin is normal and the protein concentration is very low.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Turbid or</strong> <strong>cloudy</strong> – Spontaneously infected fluid is frequently turbid or cloudy. A study of 916 samples demonstrated that an "abnormal ascitic fluid appearance" as defined as hazy, cloudy, or bloody was 98 percent sensitive, but only 23 percent specific in detecting spontaneous bacterial peritonitis [<a href="#rid58">58</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Opalescent</strong> – Infrequently, ascitic fluid in the setting of cirrhosis is "opalescent" and has a slightly elevated triglyceride concentration [<a href="#rid59">59</a>]. This peculiarity does not seem to have clinical significance except to explain the opalescence, which can be misinterpreted as "pus."</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Milky</strong> – Milky fluid usually has a triglyceride concentration that exceeds the serum concentration, is greater than 200 mg/dL (2.26 mmol/L), and is often greater than 1000 mg/dL (11.3 mmol/L); such specimens are referred to as "chylous ascites" [<a href="#rid41">41</a>]. A study performed in a tertiary referral center reported that malignancy was the most common cause of chylous ascites; however, this probably represented selection bias [<a href="#rid41">41</a>]. By contrast, a prospective study performed in large general hospitals documented that cirrhosis caused 10 times as many cases of chylous ascites as malignancy [<a href="#rid40">40</a>]. Approximately 1 out of 200 patients (0.5 percent) with cirrhosis has chylous ascites in the absence of cancer [<a href="#rid60">60</a>]. (See  <a class="medical medical_review" href="/z/d/html/1235.html" rel="external">"Chylous, bloody, and pancreatic ascites"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pink or</strong> <strong>bloody (and corrected neutrophil count)</strong> – Pink fluid usually has a red cell concentration of &gt;10,000 per mm<sup>3</sup>. Frankly bloody fluid has a red cell count of tens of thousands per mm<sup>3</sup>. Most bloody samples are due to a "traumatic tap" with trivial leakage of subcutaneous blood during the tap. In this setting, the fluid is heterogeneously bloody with clearance of the red color during the tap and clotting of the specimen if the sample is not promptly placed into the anticoagulant tube. If the fluid appears to be homogeneously bloody, the bleeding probably occurred long before the current tap with subsequent clot lysis and distribution of the red cells throughout the abdominal cavity. A rapid repeat paracentesis entering the other side of the abdomen can confirm that the fluid is homogeneously bloody.</p><p></p><p class="bulletIndent1">The differential diagnosis in this setting is bloody ascites due to cirrhosis, leakage of blood from a punctured collateral (eg, from a previous tap), or malignancy [<a href="#rid61">61,62</a>]. Of samples obtained from patients with cirrhosis, approximately 5 percent were bloody in one study [<a href="#rid61">61</a>]. Of the bloody samples, 41 percent were "spontaneous" and probably related to bloody lymph, 34 percent were due to bleeding hepatocellular carcinoma, 22 percent due to traumatic tap, and 3 percent due to tuberculous peritonitis [<a href="#rid61">61</a>]. Careful paracentesis technique minimizes the risk of puncturing a collateral vein or artery. (See  <a class="medical medical_review" href="/z/d/html/16203.html" rel="external">"Diagnostic and therapeutic abdominal paracentesis"</a>.) </p><p></p><p class="bulletIndent1">Ascites is bloody in approximately 50 percent of patients with hepatocellular carcinoma [<a href="#rid61">61-63</a>] and in 22 percent of malignancy-related ascites overall [<a href="#rid63">63</a>]. Patients with hepatocellular carcinoma can develop massive intra-abdominal bleeding with hemodynamic instability and rapid death; embolization of the bleeding vessel by an interventional radiologist can be effective in stopping the bleeding [<a href="#rid62">62,64</a>]. Such patients rarely qualify for liver transplantation due to advanced tumor stage and intraperitoneal spread. (See  <a class="medical medical_review" href="/z/d/html/1240.html" rel="external">"Malignancy-related ascites"</a>.)</p><p></p><p class="bulletIndent1">Contrary to popular belief, tuberculous peritonitis is rarely bloody [<a href="#rid61">61</a>]. (See  <a class="medical medical_review" href="/z/d/html/1238.html" rel="external">"Abdominal tuberculosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Brown</strong> – Deeply jaundiced patients have brown ascitic fluid with a bilirubin concentration approximately 40 percent of the serum value [<a href="#rid65">65</a>]. If the ascitic fluid is as brown as molasses and the bilirubin concentration is greater than the serum value, the patient likely has a ruptured gallbladder or perforated duodenal ulcer [<a href="#rid65">65</a>].</p><p></p><p class="headingAnchor" id="H64022813"><span class="h3">Serum-to-ascites albumin gradient</span><span class="headingEndMark"> — </span>The serum-to-ascites albumin gradient (SAAG) accurately identifies the presence of portal hypertension and is more useful than the protein-based exudate/transudate concept  (<a class="graphic graphic_table graphicRef62032" href="/z/d/graphic/62032.html" rel="external">table 3</a> and <a class="graphic graphic_table graphicRef81696" data-inline-graphics="81696" href="/z/d/graphic/81696.html" rel="external">table 5</a> and <a class="graphic graphic_algorithm graphicRef77605" href="/z/d/graphic/77605.html" rel="external">algorithm 1</a>) [<a href="#rid40">40,66</a>]. The SAAG is easily calculated by subtracting the ascitic fluid albumin value from the serum albumin value, which should be obtained the same day. The SAAG generally does not need to be repeated after the initial measurement.</p><p class="bulletIndent1"><span class="glyph">●</span>The presence of a gradient ≥1.1 g/dL (≥11 g/L) predicts that the patient has portal hypertension with 97 percent accuracy [<a href="#rid40">40</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>A gradient &lt;1.1 g/dL (&lt;11 g/L) indicates that the patient does not have portal hypertension [<a href="#rid40">40</a>]. </p><p></p><p>The SAAG will be elevated with any disorder leading to portal hypertension and is not specific to ascites due to cirrhosis  (<a class="graphic graphic_table graphicRef81696" href="/z/d/graphic/81696.html" rel="external">table 5</a>). Other testing may be needed to differentiate cirrhotic from noncirrhotic portal hypertension. Additional testing will depend upon the clinical setting and may include an evaluation for heart failure, hepatic metastases, or Budd-Chiari syndrome. </p><p>Patients with ascites due to heart failure can narrow their gradient during diuresis, whereas the SAAG in the setting of cirrhosis remains stable unless blood pressure or portal pressure decreases significantly.</p><p class="headingAnchor" id="H341238900"><span class="h3">Cell count and differential</span><span class="headingEndMark"> — </span>The cell count with differential is the single most useful test performed on ascitic fluid to evaluate for infection and should be ordered on every specimen, including therapeutic paracentesis specimens (ie, a paracentesis being performed as part of the treatment of ascites). Ascitic fluid infection is a reversible cause of deterioration and a preventable cause of death in patients with cirrhosis and ascites. The key to survival is early detection and treatment [<a href="#rid57">57,67</a>]. The cell count should be available within one hour, while the culture takes several hours to days [<a href="#rid68">68,69</a>]. Antibiotic treatment should be considered in any patient with a corrected neutrophil count ≥250/mm<sup>3</sup> [<a href="#rid57">57,67,69</a>]. </p><p>The fluid should be submitted to the lab in a tube containing an anticoagulant to avoid clotting (usually EDTA—"purple top" tube). Rapid turn-around may require a "stat" order. Some laboratories prioritize routine peripheral blood tests over the processing of ascitic fluid cell counts, and a call should be placed to the laboratory if the result is not rapidly available. If the results are delayed or if the clinician fails to follow-up on the cell count in a timely manner, infection may not be diagnosed until is at an advanced, and possibly fatal, stage. </p><p>The white blood cell and neutrophil counts need to be corrected in patients with bloody samples. One white blood cell should be subtracted from the white blood cell count for every 750 red blood cells to yield the "corrected white blood cell count," and one neutrophil should be subtracted from the absolute neutrophil count for every 250 red blood cells to yield the "corrected neutrophil count" [<a href="#rid70">70</a>]. In bloody ascites, the corrected neutrophil count is frequently &lt;0 due to remote hemorrhage with lysis of neutrophils. (See <a class="local">'Appearance'</a> above and  <a class="medical medical_review" href="/z/d/html/1249.html" rel="external">"Spontaneous bacterial peritonitis in adults: Diagnosis"</a>.)</p><p class="headingAnchor" id="H64022964"><span class="h3">Total protein concentration</span><span class="headingEndMark"> — </span>Ascitic fluid can be classified as an exudate if the total protein concentration is ≥2.5 or 3 g/dL and a transudate if it is below this cutoff. However, the exudate/transudate system of ascitic fluid classification has been replaced by the SAAG, which is a more useful measure for determining whether portal hypertension is present [<a href="#rid40">40</a>]. (See <a class="local">'Serum-to-ascites albumin gradient'</a> above.)</p><p>Despite its problems, the ascitic fluid total protein concentration remains of some value. This parameter does not change with development of spontaneous bacterial peritonitis (SBP), and patients with a value less than 1 g/dL have a high risk of SBP [<a href="#rid71">71,72</a>]. Selective intestinal decontamination may help prevent SBP in patients with low protein ascites [<a href="#rid73">73</a>]. (See  <a class="medical medical_review" href="/z/d/html/1248.html" rel="external">"Spontaneous bacterial peritonitis in adults: Treatment and prophylaxis", section on 'Prophylaxis'</a>.)</p><p>Measurement of total protein, glucose, and lactate dehydrogenase (LDH) in ascites may also be of value in distinguishing SBP from bowel perforation into ascites [<a href="#rid74">74,75</a>]. Patients with ascitic fluid that has a corrected neutrophil count ≥250 cells/mm<sup>3</sup> and meets two out of the following three criteria are unlikely to have SBP and warrant immediate evaluation to determine if bowel perforation into ascites has occurred [<a href="#rid74">74,75</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Total protein &gt;1 g/dL</p><p class="bulletIndent1"><span class="glyph">●</span>Glucose &lt;50 mg/dL (2.8 mmol/L)</p><p class="bulletIndent1"><span class="glyph">●</span>LDH greater than the upper limit of normal for serum</p><p></p><p>The total protein concentration may also help differentiate uncomplicated ascites from cirrhosis from cardiac ascites, both of which have a SAAG ≥1.1 g/dL (≥11 g/L). In the case of ascites from cirrhosis, the total protein is &lt;2.5 g/dL (&lt;25 g/L), whereas in cardiac ascites it is ≥2.5 g/dL (≥25 g/L). </p><p>In patients with nephrotic ascites, the SAAG is &lt;1.1 g/dL (&lt;11 g/L), and the total protein in the ascites of &lt;2.5 g/dL (&lt;25 g/L). </p><p class="headingAnchor" id="H341238921"><span class="h2">Other ascitic fluid tests</span><span class="headingEndMark"> — </span>Other tests should be ordered in appropriate settings  (<a class="graphic graphic_table graphicRef62032" href="/z/d/graphic/62032.html" rel="external">table 3</a> and <a class="graphic graphic_algorithm graphicRef77605" href="/z/d/graphic/77605.html" rel="external">algorithm 1</a>) [<a href="#rid57">57</a>]. These additional tests may be performed with the initial paracentesis if there is clinical suspicion for a particular disorder, or they may be performed on a subsequent paracentesis based on the results of initial testing. As a general rule, these tests are most useful when there is suspicion of something other than sterile ascites due to cirrhosis.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Culture </strong>– Cultures of ascitic fluid should be obtained on specimens from patients who are being admitted to the hospital with ascites and those who deteriorate with fever, abdominal pain, azotemia, acidosis, or confusion [<a href="#rid57">57</a>]. By comparison, therapeutic paracentesis samples in patients without symptoms of infection do not need to be cultured [<a href="#rid76">76,77</a>].</p><p></p><p class="bulletIndent1">An adequate volume of ascitic fluid (generally 10 mL per bottle, but the amount varies according to the manufacturer of the bottle) should be inoculated into aerobic and anaerobic blood culture bottles at the bedside; this method is more sensitive for detecting bacterial growth in ascitic fluid than conventional culture methods [<a href="#rid68">68</a>]. Bedside inoculation of the blood culture bottles is preferable to delayed inoculation of the bottles in the microbiology laboratory [<a href="#rid78">78</a>]. (See  <a class="medical medical_review" href="/z/d/html/1249.html" rel="external">"Spontaneous bacterial peritonitis in adults: Diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Glucose</strong> <strong>concentration</strong> – The ascitic fluid glucose concentration is similar to that in serum unless glucose is being consumed in the peritoneal cavity by white blood cells or bacteria [<a href="#rid71">71</a>]. Malignant cells also consume glucose; thus, the concentration of glucose may be low in peritoneal carcinomatosis [<a href="#rid63">63</a>]. In the setting of bowel perforation (eg, perforated ulcer or diverticulum) into ascitic fluid, glucose may be undetectable [<a href="#rid74">74,75</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lactate dehydrogenase</strong> <strong>concentration</strong> – Because lactate dehydrogenase (LDH) is a much larger molecule than glucose, it enters ascitic fluid less readily [<a href="#rid79">79</a>]. The ascitic fluid/serum (AF/S) ratio of LDH is approximately 0.4 in uncomplicated ascites due to cirrhosis. In SBP, the ascitic fluid LDH level rises such that the mean ratio approaches 1.0 [<a href="#rid71">71</a>]. If the LDH ratio is more than 1.0, LDH is being produced in or released into the peritoneal cavity, usually because of infection, bowel perforation, or tumor.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gram</strong> <strong>stain</strong> – Although a Gram stain of ascitic fluid is frequently ordered when SBP is suspected, careful inspection of the centrifuged sediment of 50 mL of ascites is only 10 percent sensitive in visualizing bacteria in early detected SBP [<a href="#rid68">68,80</a>], and a Gram stain of uncentrifuged fluid is positive in only 7 percent [<a href="#rid68">68</a>]. In one report, a Gram stain was positive in only 31 of 796 fluid samples; sensitivity and specificity for SBP were estimated to be 10 and 98 percent, respectively [<a href="#rid80">80</a>]. Choice of antibiotics was changed in only one patient, while 16 of 31 positive samples occurred in patients without SBP and were thought to have represented contaminants.</p><p></p><p class="bulletIndent1">Approximately 10,000 bacteria/mL are required for detection by Gram stain, while the median concentration of bacteria in SBP is only one organism/mL [<a href="#rid68">68</a>]. Thus, a Gram stain of ascitic fluid is analogous to a Gram stain of blood in bacteremia; it is only positive when there is an enormous colony count. The Gram stain is most helpful in ruling in free perforation of the bowel into ascites, in which case sheets of multiple bacterial forms can be seen  (<a class="graphic graphic_picture graphicRef77736" href="/z/d/graphic/77736.html" rel="external">picture 1</a>). A syringe or tube of fluid must be submitted to the laboratory in addition to the culture bottles when requesting a Gram stain.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Amylase</strong> <strong>concentration</strong> – The mean ascitic fluid amylase concentration is about 100 int. units/L in uncomplicated ascites due to cirrhosis, and the AF/S ratio of amylase is approximately 0.4 [<a href="#rid81">81</a>]. The ascitic fluid amylase concentration rises above this level in the setting of pancreatitis or bowel perforation into ascites [<a href="#rid75">75,81</a>]. In pancreatic ascites, the ascitic fluid amylase concentration is approximately 2000 int. unit/L, and the AF/S ratio is approximately 6.0 [<a href="#rid81">81</a>]. (See  <a class="medical medical_review" href="/z/d/html/1235.html" rel="external">"Chylous, bloody, and pancreatic ascites"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tests for tuberculous</strong> <strong>peritonitis</strong> – A variety of tests have been used for the detection of tuberculous peritonitis. When there is high suspicion of tuberculous peritonitis, peritoneoscopy with mycobacterial culture and histology of a biopsied tubercle is the most rapid route to the diagnosis. (See  <a class="medical medical_review" href="/z/d/html/1238.html" rel="external">"Abdominal tuberculosis"</a>.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Direct smear – The direct smear of ascitic fluid has only 0 to 2 percent sensitivity for detecting mycobacteria [<a href="#rid82">82</a>]. We have not encountered a single true positive ascitic fluid Mycobacterial smear.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Culture – When one liter of fluid is cultured, sensitivity for Mycobacteria reportedly reaches 62 to 83 percent [<a href="#rid82">82,83</a>]. However, most laboratories can only process 50 mL of ascitic fluid for Mycobacterial culture.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Peritoneoscopy – Peritoneoscopy with culture of a biopsy specimen has a sensitivity for detecting tuberculous peritonitis that approaches 100 percent [<a href="#rid84">84</a>]. Fluid and tissue can be sent for PCR for tuberculosis [<a href="#rid85">85</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cell count – Tuberculous peritonitis can mimic the culture-negative variant of SBP, but mononuclear cells usually predominate in tuberculosis. (See  <a class="medical medical_review" href="/z/d/html/1250.html" rel="external">"Spontaneous bacterial peritonitis variants"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Adenosine deaminase – Adenosine deaminase is a purine-degrading enzyme that is necessary for the maturation and differentiation of lymphoid cells. Adenosine deaminase activity of ascitic fluid has been proposed as a useful non-culture method of detecting tuberculous peritonitis; however, patients with tuberculous peritonitis who also have cirrhosis usually have falsely low values [<a href="#rid84">84</a>]. This test is useful in countries such as India, but it is of very limited utility in the United States because most patients in the United States with tuberculous peritonitis also have cirrhosis [<a href="#rid84">84</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cytology</strong> – Almost 100 percent of patients with peritoneal carcinomatosis will have positive ascitic fluid cytology due to the presence of viable malignant cells exfoliating into the ascitic fluid [<a href="#rid63">63</a>]. However, only about two-thirds of patients with malignancy-related ascites have peritoneal carcinomatosis. The remaining patients have massive liver metastases, chylous ascites due to lymphoma, or hepatocellular carcinoma; these patients usually have negative cytology [<a href="#rid63">63</a>]. As a result, the overall sensitivity of cytology smears for the detection of malignant ascites is 58 to 75 percent [<a href="#rid86">86,87</a>]. Hepatomas rarely metastasize to the peritoneum [<a href="#rid88">88,89</a>]. (See  <a class="medical medical_review" href="/z/d/html/1240.html" rel="external">"Malignancy-related ascites"</a>.)</p><p></p><p class="bulletIndent1">Some cytology laboratories prefer that specimens be submitted in alcohol fixative, while others prefer fresh unfixed specimens. It is best to coordinate this with the local laboratory to maximize the sensitivity of the cytology.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Carcinoembryonic antigen</strong> <strong>concentration</strong> – Measurement of carcinoembryonic antigen (CEA) in ascitic fluid has been proposed as a helpful test in detecting malignancy-related ascites [<a href="#rid90">90</a>]. However, the study that validated CEA was small and did not subgroup patients based on the type of cancer. CEA may be of some utility in ascitic fluid analysis, but its precise value remains unclear.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Triglyceride</strong> <strong>concentration</strong> – A triglyceride concentration should be obtained on ascitic fluid that is milky. Chylous ascites has a triglyceride content greater than 200 mg/dL (2.26 mmol/L) and usually greater than 1000 mg/dL (11.3 mmol/L) [<a href="#rid41">41,60</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bilirubin</strong> <strong>concentration</strong> – The bilirubin concentration should be measured in patients with brown ascites. As mentioned above, an ascitic fluid bilirubin value greater than the serum suggests bowel or biliary perforation into ascites [<a href="#rid65">65</a>]. (See <a class="local">'Appearance'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Serum pro-brain natriuretic peptide</strong> <strong>concentration</strong> – Measurement of pro-brain natriuretic peptide in serum can help distinguish ascitic fluid due to cirrhosis from ascitic fluid due to heart failure. In one report, median values were significantly higher in heart failure compared with cirrhosis, with very little overlap (6100 versus 166 pg/mL). Patients with both heart failure and cirrhosis have values in the heart failure range [<a href="#rid91">91</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Useless</strong> <strong>tests</strong> – Some tests of ascitic fluid appear to be useless. These include pH, lactate, and "humoral tests of malignancy" such as fibronectin, cholesterol, and many others [<a href="#rid69">69,92</a>].</p><p></p><p class="headingAnchor" id="H341240280"><span class="h2">Additional testing based on ascitic fluid analysis</span><span class="headingEndMark"> — </span>Based on the results of the diagnostic evaluation of the ascitic fluid, additional testing may be indicated  (<a class="graphic graphic_algorithm graphicRef77605" href="/z/d/graphic/77605.html" rel="external">algorithm 1</a>). The diagnostic approaches to the disorders associated with ascites are discussed elsewhere:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1253.html" rel="external">"Cirrhosis in adults: Etiologies, clinical manifestations, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/3485.html" rel="external">"Determining the etiology and severity of heart failure or cardiomyopathy"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/3580.html" rel="external">"Noncirrhotic portal hypertension"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1249.html" rel="external">"Spontaneous bacterial peritonitis in adults: Diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1240.html" rel="external">"Malignancy-related ascites"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1235.html" rel="external">"Chylous, bloody, and pancreatic ascites"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1238.html" rel="external">"Abdominal tuberculosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1897.html" rel="external">"Unique aspects of gastrointestinal disease in patients on dialysis", section on 'Hemodialysis-associated ascites'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/3084.html" rel="external">"Overview of heavy proteinuria and the nephrotic syndrome", section on 'Diagnosis'</a>.)</p><p></p><p class="headingAnchor" id="H2781830390"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/114698.html" rel="external">"Society guideline links: Portal hypertension and ascites"</a>.)</p><p class="headingAnchor" id="H6965805"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/16989.html" rel="external">"Patient education: Fluid in the belly (ascites) (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H39"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology </strong>– There are numerous causes of ascites  (<a class="graphic graphic_table graphicRef56069" href="/z/d/graphic/56069.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef51299" href="/z/d/graphic/51299.html" rel="external">table 2</a>), but the most common cause of ascites in the United States is cirrhosis. Other common causes of ascites include malignancy-related ascites and ascites due to heart failure. Approximately 5 percent of patients will have two or even three causes for ascites formation. (See <a class="local">'Etiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations </strong>– Patients with ascites typically report progressive abdominal distension that may be painless or associated with abdominal discomfort. The time course over which the distension develops depends upon the etiology of the ascites. It may develop over the course of days (eg, bloody ascites due to trauma) or months (eg, malignant ascites). Patients may also complain of weight gain, shortness of breath, early satiety, and dyspnea resulting from fluid accumulation and increased abdominal pressure. (See <a class="local">'Symptoms'</a> above.)</p><p></p><p class="bulletIndent1">Patients with ascites, regardless of the etiology, will typically have flank dullness on examination. Other findings include shifting dullness (a change in location of dullness to percussion when the patient is turned due to movement of the ascites) and/or evidence of pleural effusions (eg, decreased breath sounds or dullness to percussion). Patients may also have physical examination findings related to the underlying cause of the ascites, such as stigmata of cirrhosis. (See <a class="local">'Physical examination'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis </strong>– The diagnosis of ascites is established with a combination of physical examination and abdominal imaging (usually ultrasonography). Once the diagnosis of ascites is made, the next step is to look for the cause. This typically includes a paracentesis to evaluate the ascitic fluid. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Analyzing ascitic fluid </strong>– Abdominal paracentesis is crucial for determining the cause of a patient's ascites and is indicated for all patients with new onset ascites  (<a class="graphic graphic_table graphicRef64189" href="/z/d/graphic/64189.html" rel="external">table 4</a>). Analysis of the ascitic fluid can help determine if the fluid is infected and if it is due to portal hypertension or other causes  (<a class="graphic graphic_algorithm graphicRef77605" href="/z/d/graphic/77605.html" rel="external">algorithm 1</a> and <a class="graphic graphic_table graphicRef81696" href="/z/d/graphic/81696.html" rel="external">table 5</a>). (See <a class="local">'Determining the cause of the ascites'</a> above.)</p><p></p><p class="bulletIndent1">Initial tests that should be performed on the ascitic fluid include  (<a class="graphic graphic_table graphicRef62032" href="/z/d/graphic/62032.html" rel="external">table 3</a>) (see <a class="local">'Initial ascitic fluid tests'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Appearance assessment (eg, clear, bloody, cloudy, milky)</p><p class="bulletIndent2"><span class="glyph">•</span>Serum-to-ascites albumin gradient determination</p><p class="bulletIndent2"><span class="glyph">•</span>Cell count and differential</p><p class="bulletIndent2"><span class="glyph">•</span>Total protein concentration</p><p></p><p class="bulletIndent1">Additional tests that may be performed to aid in confirming a diagnosis include  (<a class="graphic graphic_table graphicRef62032" href="/z/d/graphic/62032.html" rel="external">table 3</a>) (see <a class="local">'Other ascitic fluid tests'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Culture with bedside inoculation of aerobic and anaerobic blood culture bottles</p><p class="bulletIndent2"><span class="glyph">•</span>Glucose concentration (malignancy, infection, bowel perforation)</p><p class="bulletIndent2"><span class="glyph">•</span>Lactate dehydrogenase concentration (malignancy, infection, or bowel perforation)</p><p class="bulletIndent2"><span class="glyph">•</span>Gram stain (suspected bowel perforation)</p><p class="bulletIndent2"><span class="glyph">•</span>Amylase concentration (pancreatic ascites or bowel perforation)</p><p class="bulletIndent2"><span class="glyph">•</span>Tuberculosis smear, culture, and adenosine deaminase activity (tuberculous peritonitis)</p><p class="bulletIndent2"><span class="glyph">•</span>Cytology and possibly carcinoembryonic antigen level (malignancy)</p><p class="bulletIndent2"><span class="glyph">•</span>Triglyceride concentration (chylous ascites)</p><p class="bulletIndent2"><span class="glyph">•</span>Bilirubin concentration (bowel or biliary perforation)</p><p class="bulletIndent2"><span class="glyph">•</span>Serum pro-brain natriuretic peptide (heart failure)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Runyon BA. Management of adult patients with ascites caused by cirrhosis. Hepatology 1998; 27:264.</a></li><li><a class="nounderline abstract_t">Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021; 74:1014.</a></li><li><a class="nounderline abstract_t">Runyon BA. Care of patients with ascites. N Engl J Med 1994; 330:337.</a></li><li><a class="nounderline abstract_t">Urrunaga NH, Singal AG, Cuthbert JA, Rockey DC. Hemorrhagic ascites. Clinical presentation and outcomes in patients with cirrhosis. J Hepatol 2013; 58:1113.</a></li><li class="breakAll">Norton J. Greenberger. Ascites &amp; spontaneous bacterial peritonitis. In: Current diagnosis &amp; treatment: Gastroenterology, hepatology, &amp; endoscopy, Second Edition, Norton J. Greenberger (Ed), McGraw-Hill, New York 2012. p.515.</li><li><a class="nounderline abstract_t">Vallerie AM, Lerner JP, Wright JD, Baxi LV. Peritoneal inclusion cysts: a review. Obstet Gynecol Surv 2009; 64:321.</a></li><li><a class="nounderline abstract_t">Miedema EB, Bissada NK, Finkbeiner AE, Casali RE. Chylous ascites complicating retroperitoneal lymphadenectomy for testis tumors: management with peritoneovenous shunting. J Urol 1978; 120:377.</a></li><li><a class="nounderline abstract_t">Müller-Schoop JW, Wang SP, Munzinger J, et al. Chlamydia trachomatis as possible cause of peritonitis and perihepatitis in young women. Br Med J 1978; 1:1022.</a></li><li><a class="nounderline abstract_t">Ackerman Z. Ascites in Nephrotic syndrome. Incidence, patients' characteristics, and complications. J Clin Gastroenterol 1996; 22:31.</a></li><li><a class="nounderline abstract_t">Wilkins KW Jr, Hoffman GS. Massive ascites in systemic lupus erythematosus. J Rheumatol 1985; 12:571.</a></li><li><a class="nounderline abstract_t">Mauer K, Manzione NC. Usefulness of serum-ascites albumin difference in separating transudative from exudative ascites. Another look. Dig Dis Sci 1988; 33:1208.</a></li><li><a class="nounderline abstract_t">Ryu JH, Doerr CH, Fisher SD, et al. Chylothorax in lymphangioleiomyomatosis. Chest 2003; 123:623.</a></li><li><a class="nounderline abstract_t">Dees A, Kluchert SA, van Vliet AC. Pseudo-renal failure associated with internal leakage of urine. Neth J Med 1990; 37:197.</a></li><li><a class="nounderline abstract_t">Cappell MS, Shetty V. A multicenter, case-controlled study of the clinical presentation and etiology of ascites and of the safety and clinical efficacy of diagnostic abdominal paracentesis in HIV seropositive patients. Am J Gastroenterol 1994; 89:2172.</a></li><li><a class="nounderline abstract_t">Saab S, Rickman LS, Lyche KD. Ascites and the acquired immunodeficiency syndrome. Report of 54 cases. Medicine (Baltimore) 1996; 75:131.</a></li><li><a class="nounderline abstract_t">Jamidar PA, Campbell DR, Fishback JL, Klotz SA. Peritoneal coccidioidomycosis associated with human immunodeficiency virus infection. Gastroenterology 1992; 102:1054.</a></li><li><a class="nounderline abstract_t">Fábregues F, Balasch J, Ginès P, et al. Ascites and liver test abnormalities during severe ovarian hyperstimulation syndrome. Am J Gastroenterol 1999; 94:994.</a></li><li><a class="nounderline abstract_t">Gregora MG, McNamara T. Ascites--an unusual association with pelvic inflammatory disease. Aust N Z J Obstet Gynaecol 1997; 37:477.</a></li><li><a class="nounderline abstract_t">Ross JA, Hacket E, Lawton F, Jurkovic D. Massive ascites due to abdominal pregnancy. Hum Reprod 1997; 12:390.</a></li><li><a class="nounderline abstract_t">el-Newihi HM, Antaki JP, Rajan S, Reynolds TB. Large bloody ascites in association with pelvic endometriosis: case report and literature review. Am J Gastroenterol 1995; 90:632.</a></li><li><a class="nounderline abstract_t">Paspatis GA, Kissamitaki V, Kyriakakis E, et al. Ascites associated with the initial presentation of Crohn's disease. Am J Gastroenterol 1999; 94:1974.</a></li><li><a class="nounderline abstract_t">Bourantas KL, Christou LG, Dalekos GN, et al. A 54-year-old stockbreeder with ascites. Lancet 1997; 349:994.</a></li><li><a class="nounderline abstract_t">Kapoor OP, Nathwani BN, Joshi VR. Amoebic peritonitis. A study of 73 cases. J Trop Med Hyg 1972; 75:11.</a></li><li><a class="nounderline abstract_t">Peterkin IR, Lewandowski BJ. Salmonella enteritis: a cause for ascites. Am J Gastroenterol 1993; 88:1274.</a></li><li><a class="nounderline abstract_t">Parikh VA, Edlund JW. Ascites associated with antibiotic-associated pseudomembranous colitis. South Med J 1997; 90:460.</a></li><li><a class="nounderline abstract_t">Hui JY, Woo PC, Kan PS, Tang AP. A woman with ascites and abdominal masses. Lancet 2000; 355:546.</a></li><li><a class="nounderline abstract_t">Alegre A, Martínez-Chamorro C, Fernández-Rañada JM. Massive myelomatous ascites responsive to VAD chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant 1999; 24:343.</a></li><li><a class="nounderline abstract_t">Shimoni A, Shvidel L, Shtalrid M, et al. Prolymphocytic transformation of B-chronic lymphocytic leukemia presenting as malignant ascites and pleural effusion. Am J Hematol 1998; 59:316.</a></li><li><a class="nounderline abstract_t">Runyon BA, Hoefs JC. Peritoneal lymphomatosis with ascites. A characterization. Arch Intern Med 1986; 146:887.</a></li><li><a class="nounderline abstract_t">Bonnet P, Smadja C, Szekely AM, et al. Intractable ascites in systemic mastocytosis treated by portal diversion. Dig Dis Sci 1987; 32:209.</a></li><li><a class="nounderline abstract_t">Myers TJ, Kyle RA, Jacobson DR. Familial amyloid with a transthyretin leucine 33 mutation presenting with ascites. Am J Hematol 1998; 59:249.</a></li><li><a class="nounderline abstract_t">Oren I, Goldman A, Haddad N, et al. Ascites and pleural effusion secondary to extramedullary hematopoiesis. Am J Med Sci 1999; 318:286.</a></li><li><a class="nounderline abstract_t">Abarca M, Andrade RJ, García-Arjona A, et al. Portal hypertension and refractory ascites associated with multicentric Castleman's disease. Dig Dis Sci 2000; 45:697.</a></li><li><a class="nounderline abstract_t">de Kerguenec C, Hillaire S, Molinié V, et al. Hepatic manifestations of hemophagocytic syndrome: a study of 30 cases. Am J Gastroenterol 2001; 96:852.</a></li><li><a class="nounderline abstract_t">Loeb JM, Hauger PH, Carney JD, Cooper AD. Refractory ascites due to POEMS syndrome. Gastroenterology 1989; 96:247.</a></li><li><a class="nounderline abstract_t">Iwai M, Kashiwadani M, Okuno T, et al. Cholestatic liver disease in a 20-yr-old woman with histiocytosis X. Am J Gastroenterol 1988; 83:164.</a></li><li><a class="nounderline abstract_t">Imparato AM. Gaucher's Disease With Ascites: Response to Portacaval Shunt. Ann Surg 1960; 151:431.</a></li><li><a class="nounderline abstract_t">West GA, Berger MS, Geyer JR. Childhood optic pathway tumors associated with ascites following ventriculoperitoneal shunt placement. Pediatr Neurosurg 1994; 21:254.</a></li><li><a class="nounderline abstract_t">Isenberg JI, Gilbert SB, Pitcher JL. Ascites with peritoneal involvement in Whipple's disease. Report of a case. Gastroenterology 1971; 60:305.</a></li><li><a class="nounderline abstract_t">Runyon BA, Montano AA, Akriviadis EA, et al. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med 1992; 117:215.</a></li><li><a class="nounderline abstract_t">Press OW, Press NO, Kaufman SD. Evaluation and management of chylous ascites. Ann Intern Med 1982; 96:358.</a></li><li><a class="nounderline abstract_t">Steinemann DC, Dindo D, Clavien PA, Nocito A. Atraumatic chylous ascites: systematic review on symptoms and causes. J Am Coll Surg 2011; 212:899.</a></li><li><a class="nounderline abstract_t">Browse NL, Wilson NM, Russo F, et al. Aetiology and treatment of chylous ascites. Br J Surg 1992; 79:1145.</a></li><li><a class="nounderline abstract_t">Aalami OO, Allen DB, Organ CH Jr. Chylous ascites: a collective review. Surgery 2000; 128:761.</a></li><li><a class="nounderline abstract_t">Cattau EL Jr, Benjamin SB, Knuff TE, Castell DO. The accuracy of the physical examination in the diagnosis of suspected ascites. JAMA 1982; 247:1164.</a></li><li><a class="nounderline abstract_t">Cárdenas A, Chopra S. Chylous ascites. Am J Gastroenterol 2002; 97:1896.</a></li><li><a class="nounderline abstract_t">Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003; 38:258.</a></li><li><a class="nounderline abstract_t">European Association for the Study of the Liver. Electronic address: <span class="__cf_email__" data-cfemail="74111507181b12121d171134111507181b12121d17115a1101">[email protected]</span>, European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018; 69:406.</a></li><li><a class="nounderline abstract_t">European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53:397.</a></li><li><a class="nounderline abstract_t">Tonon M, Piano S, Gambino CG, et al. Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis. Clin Gastroenterol Hepatol 2021; 19:358.</a></li><li><a class="nounderline abstract_t">Stanley MM, Ochi S, Lee KK, et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites. N Engl J Med 1989; 321:1632.</a></li><li><a class="nounderline abstract_t">Rudralingam V, Footitt C, Layton B. Ascites matters. Ultrasound 2017; 25:69.</a></li><li><a class="nounderline abstract_t">Berzigotti A, Ashkenazi E, Reverter E, et al. Non-invasive diagnostic and prognostic evaluation of liver cirrhosis and portal hypertension. Dis Markers 2011; 31:129.</a></li><li><a class="nounderline abstract_t">Aagaard J, Jensen LI, Sørensen TI, et al. Recanalized umbilical vein in portal hypertension. AJR Am J Roentgenol 1982; 139:1107.</a></li><li><a class="nounderline abstract_t">Kim JJ, Tsukamoto MM, Mathur AK, et al. Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis. Am J Gastroenterol 2014; 109:1436.</a></li><li><a class="nounderline abstract_t">Silk AW, McTigue KM. Reexamining the physical examination for obese patients. JAMA 2011; 305:193.</a></li><li><a class="nounderline abstract_t">Runyon BA, AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology 2009; 49:2087.</a></li><li><a class="nounderline abstract_t">Chinnock B, Hendey GW. Can clear ascitic fluid appearance rule out spontaneous bacterial peritonitis? Am J Emerg Med 2007; 25:934.</a></li><li><a class="nounderline abstract_t">Runyon BA, Akriviadis EA, Keyser AJ. The opacity of portal hypertension-related ascites correlates with the fluid's triglyceride concentration. Am J Clin Pathol 1991; 96:142.</a></li><li><a class="nounderline abstract_t">Rector WG Jr. Spontaneous chylous ascites of cirrhosis. J Clin Gastroenterol 1984; 6:369.</a></li><li><a class="nounderline abstract_t">DeSitter L, Rector WG Jr. The significance of bloody ascites in patients with cirrhosis. Am J Gastroenterol 1984; 79:136.</a></li><li><a class="nounderline abstract_t">Akriviadis EA. Hemoperitoneum in patients with ascites. Am J Gastroenterol 1997; 92:567.</a></li><li><a class="nounderline abstract_t">Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology 1988; 8:1104.</a></li><li><a class="nounderline abstract_t">Kung CT, Liu BM, Ng SH, et al. Transcatheter arterial embolization in the emergency department for hemodynamic instability due to ruptured hepatocellular carcinoma: analysis of 167 cases. AJR Am J Roentgenol 2008; 191:W231.</a></li><li><a class="nounderline abstract_t">Runyon BA. Ascitic fluid bilirubin concentration as a key to choleperitoneum. J Clin Gastroenterol 1987; 9:543.</a></li><li><a class="nounderline abstract_t">Hoefs JC. Serum protein concentration and portal pressure determine the ascitic fluid protein concentration in patients with chronic liver disease. J Lab Clin Med 1983; 102:260.</a></li><li><a class="nounderline abstract_t">Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis 1998; 27:669.</a></li><li><a class="nounderline abstract_t">Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology 1988; 95:1351.</a></li><li><a class="nounderline abstract_t">Runyon BA, Antillon MR. Ascitic fluid pH and lactate: insensitive and nonspecific tests in detecting ascitic fluid infection. Hepatology 1991; 13:929.</a></li><li><a class="nounderline abstract_t">Hoefs JC. Increase in ascites white blood cell and protein concentrations during diuresis in patients with chronic liver disease. Hepatology 1981; 1:249.</a></li><li><a class="nounderline abstract_t">Runyon BA, Hoefs JC. Ascitic fluid chemical analysis before, during and after spontaneous bacterial peritonitis. Hepatology 1985; 5:257.</a></li><li><a class="nounderline abstract_t">Runyon BA. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology 1986; 91:1343.</a></li><li><a class="nounderline abstract_t">Soriano G, Guarner C, Teixidó M, et al. Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology 1991; 100:477.</a></li><li><a class="nounderline abstract_t">Runyon BA, Hoefs JC. Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid. Hepatology 1984; 4:447.</a></li><li><a class="nounderline abstract_t">Akriviadis EA, Runyon BA. Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis. Gastroenterology 1990; 98:127.</a></li><li><a class="nounderline abstract_t">Kolle L, Ortiz J, Ricart E, et al. Ascitic fluid culture is not necessary in asymptomatic cirrhotic outpatients undergoing repeated therapeutic paracentesis (abstract). Hepatology 1996; 24:445A.</a></li><li><a class="nounderline abstract_t">Jeffries MA, Stern MA, Gunaratnam NT, Fontana RJ. Unsuspected infection is infrequent in asymptomatic outpatients with refractory ascites undergoing therapeutic paracentesis. Am J Gastroenterol 1999; 94:2972.</a></li><li><a class="nounderline abstract_t">Runyon BA, Antillon MR, Akriviadis EA, McHutchison JG. Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis. J Clin Microbiol 1990; 28:2811.</a></li><li><a class="nounderline abstract_t">Wilson JA, Suguitan EA, Cassidy WA, et al. Characteristics of ascitic fluid in the alcoholic cirrhotic. Dig Dis Sci 1979; 24:645.</a></li><li><a class="nounderline abstract_t">Chinnock B, Fox C, Hendey GW. Gram's stain of peritoneal fluid is rarely helpful in the evaluation of the ascites patient. Ann Emerg Med 2009; 54:78.</a></li><li><a class="nounderline abstract_t">Runyon BA. Amylase levels in ascitic fluid. J Clin Gastroenterol 1987; 9:172.</a></li><li><a class="nounderline abstract_t">al Karawi MA, Mohamed AE, Yasawy MI, et al. Protean manifestation of gastrointestinal tuberculosis: report on 130 patients. J Clin Gastroenterol 1995; 20:225.</a></li><li><a class="nounderline abstract_t">Singh MM, Bhargava AN, Jain KP. Tuberculous peritonitis. An evaluation of pathogenetic mechanisms, diagnostic procedures and therapeutic measures. N Engl J Med 1969; 281:1091.</a></li><li><a class="nounderline abstract_t">Hillebrand DJ, Runyon BA, Yasmineh WG, Rynders GP. Ascitic fluid adenosine deaminase insensitivity in detecting tuberculous peritonitis in the United States. Hepatology 1996; 24:1408.</a></li><li><a class="nounderline abstract_t">Anand BS, Schneider FE, El-Zaatari FA, et al. Diagnosis of intestinal tuberculosis by polymerase chain reaction on endoscopic biopsy specimens. Am J Gastroenterol 1994; 89:2248.</a></li><li><a class="nounderline abstract_t">Cardozo PL. A critical evaluation of 3000 cytologic analyses of pleural fluid, ascitic fluid, and pericardial fluid. Acta Cyto 1966; 10:455.</a></li><li><a class="nounderline abstract_t">DiBonito L, Falconieri G, Colautti I, et al. The positive peritoneal effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation. Acta Cytol 1993; 37:483.</a></li><li><a class="nounderline abstract_t">Chetty R, Learmonth GM, Taylor DA. Giant cell hepatocellular carcinoma. Cytopathology 1990; 1:233.</a></li><li><a class="nounderline abstract_t">Matsukuma S, Sato K. Peritoneal seeding of hepatocellular carcinoma: clinicopathological characteristics of 17 autopsy cases. Pathol Int 2011; 61:356.</a></li><li><a class="nounderline abstract_t">Loewenstein MS, Rittgers RA, Feinerman AE, et al. Carcinoembryonic antigen assay of ascites and detection of malignancy. Ann Intern Med 1978; 88:635.</a></li><li><a class="nounderline abstract_t">Sheer TA, Joo E, Runyon BA. Usefulness of serum N-terminal-ProBNP in distinguishing ascites due to cirrhosis from ascites due to heart failure. J Clin Gastroenterol 2010; 44:e23.</a></li><li><a class="nounderline abstract_t">Runyon BA. Malignancy-related ascites and ascitic fluid "humoral tests of malignancy". J Clin Gastroenterol 1994; 18:94.</a></li></ol></div><div id="topicVersionRevision">Topic 1261 Version 39.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9425946" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Management of adult patients with ascites caused by cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33942342" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8277955" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Care of patients with ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23348236" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Hemorrhagic ascites. Clinical presentation and outcomes in patients with cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23348236" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Hemorrhagic ascites. Clinical presentation and outcomes in patients with cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19386139" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Peritoneal inclusion cysts: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/682267" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Chylous ascites complicating retroperitoneal lymphadenectomy for testis tumors: management with peritoneovenous shunting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/638581" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Chlamydia trachomatis as possible cause of peritonitis and perihepatitis in young women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8776092" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Ascites in Nephrotic syndrome. Incidence, patients' characteristics, and complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4045854" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Massive ascites in systemic lupus erythematosus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3168691" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Usefulness of serum-ascites albumin difference in separating transudative from exudative ascites. Another look.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12576391" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Chylothorax in lymphangioleiomyomatosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2074911" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Pseudo-renal failure associated with internal leakage of urine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7977236" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : A multicenter, case-controlled study of the clinical presentation and etiology of ascites and of the safety and clinical efficacy of diagnostic abdominal paracentesis in HIV seropositive patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8965682" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Ascites and the acquired immunodeficiency syndrome. Report of 54 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1531643" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Peritoneal coccidioidomycosis associated with human immunodeficiency virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10201472" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Ascites and liver test abnormalities during severe ovarian hyperstimulation syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9429721" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Ascites--an unusual association with pelvic inflammatory disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9070733" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Massive ascites due to abdominal pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7717323" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Large bloody ascites in association with pelvic endometriosis: case report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10406275" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Ascites associated with the initial presentation of Crohn's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9100627" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : A 54-year-old stockbreeder with ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4333673" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Amoebic peritonitis. A study of 73 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8338100" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Salmonella enteritis: a cause for ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9114846" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Ascites associated with antibiotic-associated pseudomembranous colitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10683006" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : A woman with ascites and abdominal masses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10455378" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Massive myelomatous ascites responsive to VAD chemotherapy and autologous stem cell transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9840914" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Prolymphocytic transformation of B-chronic lymphocytic leukemia presenting as malignant ascites and pleural effusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3963980" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Peritoneal lymphomatosis with ascites. A characterization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3803146" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Intractable ascites in systemic mastocytosis treated by portal diversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9798666" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Familial amyloid with a transthyretin leucine 33 mutation presenting with ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10522557" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Ascites and pleural effusion secondary to extramedullary hematopoiesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10759237" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Portal hypertension and refractory ascites associated with multicentric Castleman's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11280564" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Hepatic manifestations of hemophagocytic syndrome: a study of 30 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2535829" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Refractory ascites due to POEMS syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3257640" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Cholestatic liver disease in a 20-yr-old woman with histiocytosis X.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17859623" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Gaucher's Disease With Ascites: Response to Portacaval Shunt.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7865412" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Childhood optic pathway tumors associated with ascites following ventriculoperitoneal shunt placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4101101" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Ascites with peritoneal involvement in Whipple's disease. Report of a case.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1616215" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7059101" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Evaluation and management of chylous ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21398159" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Atraumatic chylous ascites: systematic review on symptoms and causes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1467885" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Aetiology and treatment of chylous ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11056439" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Chylous ascites: a collective review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7057606" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : The accuracy of the physical examination in the diagnosis of suspected ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12190151" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Chylous ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12830009" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29653741" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20633946" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32272250" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2586565" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28567101" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Ascites matters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22045398" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Non-invasive diagnostic and prognostic evaluation of liver cirrhosis and portal hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6983253" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Recanalized umbilical vein in portal hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25091061" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21191004" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Reexamining the physical examination for obese patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19475696" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Management of adult patients with ascites due to cirrhosis: an update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17920980" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Can clear ascitic fluid appearance rule out spontaneous bacterial peritonitis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2069132" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : The opacity of portal hypertension-related ascites correlates with the fluid's triglyceride concentration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6481122" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Spontaneous chylous ascites of cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6320636" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : The significance of bloody ascites in patients with cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9128301" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Hemoperitoneum in patients with ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3417231" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Ascitic fluid analysis in malignancy-related ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19020209" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Transcatheter arterial embolization in the emergency department for hemodynamic instability due to ruptured hepatocellular carcinoma: analysis of 167 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3680904" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Ascitic fluid bilirubin concentration as a key to choleperitoneum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6864073" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Serum protein concentration and portal pressure determine the ascitic fluid protein concentration in patients with chronic liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9798013" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Spontaneous bacterial peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3049220" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Optimization of ascitic fluid culture technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2029997" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Ascitic fluid pH and lactate: insensitive and nonspecific tests in detecting ascitic fluid infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7286905" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Increase in ascites white blood cell and protein concentrations during diuresis in patients with chronic liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3979958" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Ascitic fluid chemical analysis before, during and after spontaneous bacterial peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3770358" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1985045" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Selective intestinal decontamination prevents spontaneous bacterial peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6724512" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2293571" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Ascitic fluid culture is not necessary in asymptomatic cirrhotic outpatients undergoing repeated therapeutic paracentesis (abstract)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10520854" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Unsuspected infection is infrequent in asymptomatic outpatients with refractory ascites undergoing therapeutic paracentesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2280015" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/467216" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Characteristics of ascitic fluid in the alcoholic cirrhotic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19201060" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Gram's stain of peritoneal fluid is rarely helpful in the evaluation of the ascites patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2437177" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Amylase levels in ascitic fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7797832" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Protean manifestation of gastrointestinal tuberculosis: report on 130 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5824174" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Tuberculous peritonitis. An evaluation of pathogenetic mechanisms, diagnostic procedures and therapeutic measures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8938171" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Ascitic fluid adenosine deaminase insensitivity in detecting tuberculous peritonitis in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7977255" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Diagnosis of intestinal tuberculosis by polymerase chain reaction on endoscopic biopsy specimens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : A critical evaluation of 3000 cytologic analyses of pleural fluid, ascitic fluid, and pericardial fluid</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8328242" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : The positive peritoneal effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1966267" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Giant cell hepatocellular carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21615611" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Peritoneal seeding of hepatocellular carcinoma: clinicopathological characteristics of 17 autopsy cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/646247" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Carcinoembryonic antigen assay of ascites and detection of malignancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19448570" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Usefulness of serum N-terminal-ProBNP in distinguishing ascites due to cirrhosis from ascites due to heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8189030" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Malignancy-related ascites and ascitic fluid "humoral tests of malignancy".</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
